Annual CFO
-$70.67 M
-$12.91 M-22.36%
31 December 2023
Summary:
Inozyme Pharma annual cash flow from operations is currently -$70.67 million, with the most recent change of -$12.91 million (-22.36%) on 31 December 2023. During the last 3 years, it has fallen by -$34.70 million (-96.46%). INZY annual CFO is now -648.91% below its all-time high of -$9.44 million, reached on 31 December 2018.INZY Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$24.53 M
-$870.00 K-3.68%
30 September 2024
Summary:
Inozyme Pharma quarterly cash flow from operations is currently -$24.53 million, with the most recent change of -$870.00 thousand (-3.68%) on 30 September 2024. Over the past year, it has dropped by -$5.66 million (-30.00%). INZY quarterly CFO is now -639.46% below its all-time high of -$3.32 million, reached on 30 September 2019.INZY Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$91.21 M
-$5.66 M-6.62%
30 September 2024
Summary:
Inozyme Pharma TTM cash flow from operations is currently -$91.21 million, with the most recent change of -$5.66 million (-6.62%) on 30 September 2024. Over the past year, it has dropped by -$24.62 million (-36.97%). INZY TTM CFO is now -1624.77% below its all-time high of -$5.29 million, reached on 31 March 2019.INZY TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INZY Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -22.4% | -30.0% | -37.0% |
| 3 y3 years | -96.5% | -99.4% | -100.1% |
| 5 y5 years | -648.9% | -639.5% | -576.1% |
INZY Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -96.5% | at low | -99.4% | +0.0% | -100.1% | at low |
| 5 y | 5 years | -648.9% | at low | -639.5% | +0.0% | -576.1% | at low |
| alltime | all time | -648.9% | at low | -639.5% | +0.0% | -1624.8% | at low |
Inozyme Pharma Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$24.53 M(+3.7%) | -$91.21 M(+6.6%) |
| June 2024 | - | -$23.66 M(-3.6%) | -$85.55 M(+10.5%) |
| Mar 2024 | - | -$24.53 M(+32.7%) | -$77.44 M(+9.6%) |
| Dec 2023 | -$70.67 M(+22.4%) | -$18.49 M(-2.0%) | -$70.67 M(+6.1%) |
| Sept 2023 | - | -$18.87 M(+21.4%) | -$66.59 M(+7.0%) |
| June 2023 | - | -$15.55 M(-12.5%) | -$62.23 M(+1.4%) |
| Mar 2023 | - | -$17.77 M(+23.4%) | -$61.37 M(+6.3%) |
| Dec 2022 | -$57.76 M(+20.0%) | -$14.40 M(-0.8%) | -$57.76 M(+1.7%) |
| Sept 2022 | - | -$14.51 M(-1.2%) | -$56.80 M(+4.1%) |
| June 2022 | - | -$14.69 M(+3.7%) | -$54.59 M(+9.3%) |
| Mar 2022 | - | -$14.16 M(+5.3%) | -$49.94 M(+3.7%) |
| Dec 2021 | -$48.15 M | -$13.44 M(+9.3%) | -$48.15 M(+5.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$12.30 M(+22.6%) | -$45.58 M(+4.8%) |
| June 2021 | - | -$10.03 M(-18.9%) | -$43.48 M(+3.3%) |
| Mar 2021 | - | -$12.38 M(+13.8%) | -$42.09 M(+17.0%) |
| Dec 2020 | -$35.97 M(+91.2%) | -$10.88 M(+6.6%) | -$35.97 M(+18.3%) |
| Sept 2020 | - | -$10.20 M(+18.2%) | -$30.42 M(+29.3%) |
| June 2020 | - | -$8.63 M(+37.8%) | -$23.54 M(+18.9%) |
| Mar 2020 | - | -$6.26 M(+17.8%) | -$19.79 M(+5.2%) |
| Dec 2019 | -$18.81 M(+99.3%) | -$5.32 M(+60.4%) | -$18.81 M(+39.4%) |
| Sept 2019 | - | -$3.32 M(-32.1%) | -$13.49 M(+32.6%) |
| June 2019 | - | -$4.88 M(-7.6%) | -$10.17 M(+92.4%) |
| Mar 2019 | - | -$5.29 M | -$5.29 M |
| Dec 2018 | -$9.44 M | - | - |
FAQ
- What is Inozyme Pharma annual cash flow from operations?
- What is the all time high annual CFO for Inozyme Pharma?
- What is Inozyme Pharma annual CFO year-on-year change?
- What is Inozyme Pharma quarterly cash flow from operations?
- What is the all time high quarterly CFO for Inozyme Pharma?
- What is Inozyme Pharma quarterly CFO year-on-year change?
- What is Inozyme Pharma TTM cash flow from operations?
- What is the all time high TTM CFO for Inozyme Pharma?
- What is Inozyme Pharma TTM CFO year-on-year change?
What is Inozyme Pharma annual cash flow from operations?
The current annual CFO of INZY is -$70.67 M
What is the all time high annual CFO for Inozyme Pharma?
Inozyme Pharma all-time high annual cash flow from operations is -$9.44 M
What is Inozyme Pharma annual CFO year-on-year change?
Over the past year, INZY annual cash flow from operations has changed by -$12.91 M (-22.36%)
What is Inozyme Pharma quarterly cash flow from operations?
The current quarterly CFO of INZY is -$24.53 M
What is the all time high quarterly CFO for Inozyme Pharma?
Inozyme Pharma all-time high quarterly cash flow from operations is -$3.32 M
What is Inozyme Pharma quarterly CFO year-on-year change?
Over the past year, INZY quarterly cash flow from operations has changed by -$5.66 M (-30.00%)
What is Inozyme Pharma TTM cash flow from operations?
The current TTM CFO of INZY is -$91.21 M
What is the all time high TTM CFO for Inozyme Pharma?
Inozyme Pharma all-time high TTM cash flow from operations is -$5.29 M
What is Inozyme Pharma TTM CFO year-on-year change?
Over the past year, INZY TTM cash flow from operations has changed by -$24.62 M (-36.97%)